Detail
| RLID: | RLID00035349 |
| RNA Symbol: | hsa-miR-1246 |
| RNA Category: | miRNA |
| Organism: | Homo sapiens |
| Subcellular Localization: | |
| Localization | Tissue | Validated Method | PMID |
| Mitochondrion | HeLa cell | Microarray|RT-PCR | 21695135 |
| Description: While 44 miRNAs showed a greater enrichment in the cytosolic Hy3-labeled RNA fraction, 13 miRNAs were significantly and reproducibly enriched in the mitochondrial Hy5-labeled RNA sample (ranging from 1.5- to 56-fold), namely hsa-miR-1973, hsa-miR-1275, hsa-miR-494, hsa-miR-513a-5p, hsa-miR-1246, hsa-miR-328, hsa-miR-1908, hsa-miR-1972, hsa-miR-1974, hsa-miR-1977, hsa-miR-638, hsa-miR-1978 and hsa-miR-1201 (Figure 5A). Data are collected from Figure 5. | |||
Other Subcellular Localization:
| RLID | Localization | Tissue | Validated Method | PMID |
| RLID00035334 | Circulating | Cerebrospinal fluid | Next-generation sequencing|RT-PCR | 23525801 |
| RLID00035335 | Circulating | Serum | Next-generation sequencing | 23641832 |
| RLID00035336 | Circulating | Serum | Next-generation sequencing | 24904649 |
| RLID00035337 | Extracellular vesicle | HEK293T|HMEC-1|Mononuclear cell | Next-generation sequencing | 22849433 |
| RLID00035338 | Exosome | Breast cancer cell | Microarray | 20976003 |
| RLID00035339 | Exosome | Malignant melanoma cell | Microarray | 23056502 |
| RLID00035340 | Circulating | Serum | Microarray | 23169280 |
| RLID00035341 | Exosome | Plasma | Next-generation sequencing | 23663360 |
| RLID00035342 | Mitochondrion | HeLa cell | Microarray | 21695135 |
| RLID00035343 | Mitochondrion | HeLa cell | Next-generation sequencing | 22984580 |
| RLID00035344 | Mitochondrion | Eembryonic kidney cell | Next-generation sequencing | 22984580 |
| RLID00035345 | Nucleus | HeLa cell | Next-generation sequencing | 22058130 |
| RLID00035346 | Exosome | Colon Cancer Cell Line | qRT-PCR|RNA-seq | 25330373 |
| RLID00035347 | Circulating | Serum | Microarray | 24858071 |
| RLID00035348 | Exosome | Serum | Next-generation sequencing | 24683445 |
| RLID00035350 | Circulating | Serum | Next-generation sequencing | 22719975 |